SLDB - Solid Biosciences Inc.

NasdaqGS - NasdaqGS Real Time Price. Currency in USD

Cash Flow

Annual
All numbers in thousands
Period Ending12/31/201812/31/201712/31/201612/31/2015
Net Income-74,798-52,118-21,539-6,377
Operating Activities, Cash Flows Provided By or Used In
Depreciation1,5664485656
Adjustments To Net Income5,8694,017-1,422585
Changes In Accounts Receivables----
Changes In Liabilities-1,6101,5792,213585
Changes In Inventories----
Changes In Other Operating Activities-1,2242,8505721,003
Total Cash Flow From Operating Activities-70,197-43,224-20,120-4,204
Investing Activities, Cash Flows Provided By or Used In
Capital Expenditure-7,776-2,276-392-392
Investments-18,98612,724-3,660-26,806
Other Cash flows from Investing Activities----
Total Cash Flows From Investing Activities-26,76210,448-4,052-26,806
Financing Activities, Cash Flows Provided By or Used In
Dividends Paid----
Sale Purchase of Stock----
Net Borrowings-13-13-13-13
Other Cash Flows from Financing Activities-2,168-2,924-2,92444,752
Total Cash Flows From Financing Activities131,50777,0783,42051,592
Effect Of Exchange Rate Changes----
Change In Cash and Cash Equivalents34,54844,302-20,75220,582